ITHUF - iAnthus Capital Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

iAnthus Capital Holdings, Inc.

505 5th Avenue
Floor 23
New York, NY 10017
United States
646-518-9411
http://www.ianthus.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees223

Key Executives

NameTitlePayExercisedYear Born
Mr. Randy MaslowCo-Founder, Pres, MD, Interim CEO & Director397.12kN/AN/A
Mr. Julius John KalcevichCFO & Corp. Sec.300.4kN/AN/A
Dr. Richard J. BoxerChief Medical Officer23.46kN/AN/A
Mr. Pat TiernanChief Operating OfficerN/AN/AN/A
Ms. Megan W. Kulick CFAVP of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. As of March 12, 2020, it operated 31 dispensaries in 11 states. The company is based in New York, New York.

Corporate Governance

iAnthus Capital Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.